News about Global Pharma

JB Pharma Publishes its 2nd Sustainability (ESG) Report

The report reflects JB Pharma’s priorities in building sustainable, equitable and resilient systems to promulgate good health for the current and future generations.

Global Pharma | 13/09/2023 | By Manvi |  775

Bormioli Pharma Launches 'Plastic Academy'

Bormioli Pharma is launching the Plastic Academy, a training project designed to launch young talents into the profession of plastics processing technician.

Global Pharma | 13/09/2023 | By Manvi |  845

Mirum Pharmaceuticals Announces the Appointment of Eric Bjerkholt as CFO

Bjerkholt brings extensive business leadership experience from roles served in the biopharmaceutical industry. He comes to Mirum from Chinook Therapeutics, Inc., where he served as CFO overseeing financial reporting, planning and budgeting, internal controls, investor relations, facilities, and information technology functions.

Global Pharma | 12/09/2023 | By Manvi |  777

Laurus Labs Limited Acquires Stake in Laurus Bio Private Limited

Pursuant to the above acquisition, the stake of the Company in Laurus Bio Private Limited shall reach to 87.58% on fully diluted basis (including outstanding ESOPs and the Share Warrants).

Global Pharma | 12/09/2023 | By Manvi |  1834

Norgine Appoints Saulo Martiniano as Chief Operating Officer

Saulo joins Norgine with a wealth of experience and a unique blend of leadership, operational expertise, and a deep understanding of manufacturing operational excellence and supply chain.

Global Pharma | 12/09/2023 | By Manvi |  454

Aurobindo Pharma's Telangana Plant Classified as VAI by US FDA

Pharmaceutical major Aurobindo Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Unit III in the Bachupally Village, Telangana .

Global Pharma | 11/09/2023 | By Manvi |  1591

Strides Receives USFDA Approval for Sevelamer Carbonate for Oral Suspension

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Renvela for Oral Suspension, 0.8g and 2.4g of Genzyme.

Global Pharma | 11/09/2023 | By Manvi |  439

Natco Pharma, Others Sued in US for Generic Cancer Drug

Natco Pharma said the company and other drug makers have been named defendants in an antitrust lawsuit regarding a generic cancer treatment drug in the US.

Global Pharma | 11/09/2023 | By Manvi |  583

Strides Pharma Science Limited to Acquire 100% in Strides Pharma Services Pvt Ltd

Post the said acquisition, SPSPL shall be a direct WOS of the Company.

Global Pharma | 08/09/2023 | By Manvi |  1600

US FDA Inspects Aurobindo Pharma's Unit III in Telangana

The Unit has now received an Establishment Inspection Report classifying the facility as 'Voluntary Action Indicated' (VAI).

Global Pharma | 08/09/2023 | By Manvi |  836